Loading...
| A01591 | Pages: 245 | Jan 2022 | 12196 Views | | |
| Author(s) : Vishal Bhardwaj, Ajinkya Alhat , Onkar Sumant | Tables: 147 | Charts: 43 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Multiplex Assay Market
Request Now !The global multiplex assay market size was valued at $1,940.49 million in 2020, and is projected to reach $4,366.32 million by 2030, registering a CAGR of 8.3% from 2021 to 2030. Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, and chemokines) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, and forensic studies.
During the pandemic, multiplex assays like SARS-CoV-2 assay were used for covid diagnosis which created massive demand in the market. Moreover, various companies have also received FDA emergency use authorization. Therefore, the COVID-19 pandemic is expected to have a positive impact on the market.
The multiplex assay market is witnessing significant growth, owing to increase in R&D activities in the pharmaceutical sector for treatment of several diseases. These assays are used in clinical trials as they decrease the cost of research & manual labor and increase the efficiency of experiments and therapies. In addition, they offer easier & faster analysis of diseases, and are automated, thus propel the multiplex assay market growth. However, high capital investments and dearth of skilled labors are the major factors that hinder the market growth.
Get more information on this report : Request Sample Pages
The outbreak of COVID-19 has disrupted workflows in the health care sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The overall impact of the COVID-19 pandemic remained positive for key players in the multiplex assay industry. As multiplex assays are been used for covid diagnosis, there has been a massive demand of multiplex of the SARS-CoV-2 assay such as multiplex point-of-care assays is positively boosting the growth of the multiplex assay market during the pandemic. Several companies received the FDA emergency use authorization for their COVID-19 multiplex assays to meet the soaring demand of the high volume of testing.
Get more information on this report : Request Sample Pages
The global multiplex assays market in this report is studied based on type, product, application, end user, and region. On the basis of type, the market is divided protein based multiplex assays, nucleic acid-based multiplex assay, and other multiplex assays. By product, the market is classified into reagents & consumables, instruments & accessories, and software & services. The applications covered in the study include clinical diagnostics, research & development, and companion diagnostics. As per end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceutical & biotechnology companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By type, the protein based multiplex assay segment currently dominates the global multiplex assay market and is expected to continue during the forecast period owing to the upsurge in adoption of protein based multiplex assays, and continuously investing in R&D for the introduction of innovative technology.
Get more information on this report : Request Sample Pages
By product, the reagents and consumables segment dominated the global multiplex assay market in 2020. This is attributed to rising demand increasing demand of consumables and the recurring purchase of assays and reagents for increasing research applications.
By application, the research and development segment dominated the global multiplex assay market in 2020 and is anticipated to be dominant owing to wide applications of multiplex assay technologies in research & development functions and convenience and quicker results offered by the multiplex assays while performing assays.
Get more information on this report : Request Sample Pages
By end users, the pharmaceutical and biotechnology companies segment dominated the global multiplex assay market in 2020 and is anticipated to be dominant in the market owing to rise in penetration of multiplex assays in pharmaceutical and biotechnological companies, as compared to conventional assays, for biomolecules detection, biomarker validation, and measuring the pathways for diseases & physiological activities.
Get more information on this report : Request Sample Pages
Region wise, North America dominated the multiplex assay market in 2020, owing to increase in government funds for the detection of new biomarkers, rise in R&D activates of new drugs and diagnosis & treatment options, as well as surge in prevalence of chronic diseases such as cancer and strokes in the region in the region. However, Asia-Pacific region is expected to witness considerable market growth during the forecast period, due to increase in per capita income in many countries, rise in government initiatives for the improvement of the healthcare sector, and surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries.
The key players in this multiplex assay market have adopted product launch as one of their key developmental strategies such as business expansion and collaboration. The major companies profiled in this report include Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in R&D activities & government funding
3.5.1.2.Surge in adoption of multiplex assays to reduce operation costs
3.5.1.3.Rise in adoption of personalized medicines
3.5.2.Restraint
3.5.2.1.Lack of skilled labor/healthcare professionals
3.5.3.Opportunity
3.5.3.1.Various growth opportunities in emerging economies
3.6.COVID-19 impact analysis on multiplex assay market
CHAPTER 4:MULTIPLEX ASSAY MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Protein based multiplex assays
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Nucleic Acid-Based Multiplex Assay
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Other multiplex assays
4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:MULTIPLEX ASSAY MARKET, BY PRODUCT
5.1.Overview
5.1.1.Market size and forecast
5.2.Reagents and Consumables
5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Instruments and Accessories
5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.4.Software & Services
5.4.1.Key market trends and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
CHAPTER 6:MULTIPLEX ASSAY MARKET, BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Clinical Diagnostics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Research and development
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Companion Diagnostics
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:MULTIPLEX ASSAY MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospitals
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.3.Clinical Laboratories
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
7.4.Research Institutes
7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country
7.5.Pharmaceutical & biotechnology companies
7.5.1.Market size and forecast, by region
7.5.2.Market analysis, by country
CHAPTER 8:MULTIPLEX ASSAY MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country
8.2.2.1.U.S.
8.2.2.1.1.U.S. Multiplex Assay Market, by type
8.2.2.1.2.U.S. Multiplex Assay Market, by product
8.2.2.1.3.U.S. Multiplex Assay Market, by application
8.2.2.1.4.U.S. Multiplex Assay Market, by end user
8.2.2.2.Canada
8.2.2.2.1.Canada Multiplex Assay Market, by type
8.2.2.2.2.Canada Multiplex Assay Market, by product
8.2.2.2.3.Canada Multiplex Assay Market, by application
8.2.2.2.4.Canada Multiplex Assay Market, by end user
8.2.2.3.Mexico
8.2.2.3.1.Mexico Multiplex Assay Market, by type
8.2.2.3.2.Mexico Multiplex Assay Market, by product
8.2.2.3.3.Mexico Multiplex Assay Market, by application
8.2.2.3.4.Mexico Multiplex Assay Market, by end user
8.2.3.North America market size and forecast, by type
8.2.4.North America market size and forecast, by product
8.2.5.North America market size and forecast, by application
8.2.6.North America market size and forecast, by end user
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany
8.3.2.1.1.Germany Multiplex Assay Market, by type
8.3.2.1.2.Germany Multiplex Assay Market, by product
8.3.2.1.3.Germany Multiplex Assay Market, by application
8.3.2.1.4.Germany Multiplex Assay Market, by end user
8.3.2.2.France
8.3.2.2.1.France Multiplex Assay Market, by type
8.3.2.2.2.France Multiplex Assay Market, by product
8.3.2.2.3.France Multiplex Assay Market, by application
8.3.2.2.4.France Multiplex Assay Market, by end user
8.3.2.3.UK
8.3.2.3.1.UK Multiplex Assay Market, by type
8.3.2.3.2.UK Multiplex Assay Market, by product
8.3.2.3.3.UK Multiplex Assay Market, by application
8.3.2.3.4.UK Multiplex Assay Market, by end user
8.3.2.4.Italy
8.3.2.4.1.Italy Multiplex Assay Market, by type
8.3.2.4.2.Italy Multiplex Assay Market, by product
8.3.2.4.3.Italy Multiplex Assay Market, by application
8.3.2.4.4.Italy Multiplex Assay Market, by end user
8.3.2.5.Spain
8.3.2.5.1.Spain Multiplex Assay Market, by type
8.3.2.5.2.Spain Multiplex Assay Market, by product
8.3.2.5.3.Spain Multiplex Assay Market, by application
8.3.2.5.4.Spain Multiplex Assay Market, by end user
8.3.2.6.Rest of Europe
8.3.2.6.1.Rest of Europe Multiplex Assay Market, by type
8.3.2.6.2.Rest of Europe Multiplex Assay Market, by product
8.3.2.6.3.Rest of Europe Multiplex Assay Market, by application
8.3.2.6.4.Rest of Europe Multiplex Assay Market, by end user
8.3.3.Europe market size and forecast, by type
8.3.4.Europe market size and forecast, by product
8.3.5.Europe market size and forecast, by application
8.3.6.Europe market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.Japan
8.4.2.1.1.Japan Multiplex Assay Market, by type
8.4.2.1.2.Japan Multiplex Assay Market, by product
8.4.2.1.3.Japan Multiplex Assay Market, by application
8.4.2.1.4.Japan Multiplex Assay Market, by end user
8.4.2.2.China
8.4.2.2.1.China Multiplex Assay Market, by type
8.4.2.2.2.China Multiplex Assay Market, by product
8.4.2.2.3.China Multiplex Assay Market, by application
8.4.2.2.4.China Multiplex Assay Market, by end user
8.4.2.3.Australia
8.4.2.3.1.Australia Multiplex Assay Market, by type
8.4.2.3.2.Australia Multiplex Assay Market, by product
8.4.2.3.3.Australia Multiplex Assay Market, by application
8.4.2.3.4.Australia Multiplex Assay Market, by end user
8.4.2.4.India
8.4.2.4.1.India Multiplex Assay Market, by type
8.4.2.4.2.India Multiplex Assay Market, by product
8.4.2.4.3.India Multiplex Assay Market, by application
8.4.2.4.4.India Multiplex Assay Market, by end user
8.4.2.5.Rest of Asia-Pacific
8.4.2.5.1.Rest of Asia-Pacific Multiplex Assay Market, by type
8.4.2.5.2.Rest of Asia-Pacific Multiplex Assay Market, by product
8.4.2.5.3.Rest of Asia-Pacific Multiplex Assay Market, by application
8.4.2.5.4.Rest of Asia-Pacific Multiplex Assay Market, by end user
8.4.3.Asia-Pacific market size and forecast, by type
8.4.4.Asia-Pacific market size and forecast, by product
8.4.5.Asia-Pacific market size and forecast, by application
8.4.6.Asia-Pacific market size and forecast, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil
8.5.2.1.1.Brazil Multiplex Assay Market, by type
8.5.2.1.2.Brazil Multiplex Assay Market, by product
8.5.2.1.3.Brazil Multiplex Assay Market, by application
8.5.2.1.4.Brazil Multiplex Assay Market, by end user
8.5.2.2.Saudi Arabia
8.5.2.2.1.Saudi Arabia Multiplex Assay Market, by type
8.5.2.2.2.Saudi Arabia Multiplex Assay Market, by product
8.5.2.2.3.Saudi Arabia Multiplex Assay Market, by application
8.5.2.2.4.Saudi Arabia Multiplex Assay Market, by end user
8.5.2.3.South Africa
8.5.2.3.1.South Africa Multiplex Assay Market, by type
8.5.2.3.2.South Africa Multiplex Assay Market, by product
8.5.2.3.3.South Africa Multiplex Assay Market, by application
8.5.2.3.4.South Africa Multiplex Assay Market, by end user
8.5.2.4.Rest of LAMEA
8.5.2.4.1.Rest of LAMEA Multiplex Assay Market, by type
8.5.2.4.2.Rest of LAMEA Multiplex Assay Market, by product
8.5.2.4.3.Rest of LAMEA Multiplex Assay Market, by application
8.5.2.4.4.Rest of LAMEA Multiplex Assay Market, by end user
8.5.3.LAMEA market size and forecast, by type
8.5.4.LAMEA market size and forecast, by product
8.5.5.LAMEA market size and forecast, by application
8.5.6.LAMEA market size and forecast, by end user
CHAPTER 9:COMPANY PROFILES
9.1.ABCAM PLC.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.BECTON, DICKINSON, AND COMPANY (BD BIOSCIENCES)
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.MESO SCALE DIAGNOSTICS LLC
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.4.SEEGENE INC.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.5.BIO-RAD LABORATORIES, INC.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments
9.6.ILLUMINA, INC.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.QIAGEN N.V.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.THERMO FISHER SCIENTIFIC, INC.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.LUMINEX CORPORATION
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.RANDOX LABORATORIES LTD.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
LIST OF TABLES
TABLE 01.MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 02.MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY REGION, 2020–2030 ($MILLION)
TABLE 03.MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY REGION, 2020–2030 ($MILLION)
TABLE 04.MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY REGION, 2020–2030 ($MILLION)
TABLE 05.MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 06.MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020–2030 ($MILLION)
TABLE 07.MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2020–2030 ($MILLION)
TABLE 08.MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 09.MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 10.MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2020–2030 ($MILLION)
TABLE 12.MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2020–2030 ($MILLION)
TABLE 13.MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 14.MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY REGION, 2020–2030 ($MILLION)
TABLE 15.MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020–2030 ($MILLION)
TABLE 16.MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020–2030 ($MILLION)
TABLE 17.MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2030 ($MILLION)
TABLE 18.MULTIPLEX ASSAY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20.U.S. MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 21.U.S. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 22.U.S. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.U.S. MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 24.CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 25.CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 26.CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27.CANADA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 28.MEXICO MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 29.MEXICO MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 30.MEXICO MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 31.MEXICO MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 33.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 34.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36.EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 37.GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 38.GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 39.GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 40.GERMANY MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 41.FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 42.FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 43.FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44.FRANCE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45.UK MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 46.UK MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 47.UK MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 48.UK MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 49.ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 50.ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 51.ITALY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 52.ITALY MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 53.SPAIN MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 54.SPAIN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 55.SPAIN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 56.SPAIN MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 57.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 58.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 59.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 60.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61.EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 62.EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 63.EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 64.EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 65.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 66.JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 67.JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 68.JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69.JAPAN MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70.CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 71.CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 72.CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 73.CHINA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74.AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 75.AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 76.AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 77.AUSTRALIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 78.INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 79.INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 80.INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 81.INDIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 82.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 83.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 84.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 87.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 88.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 89.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 90.LAMEA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 91.BRAZIL MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 92.BRAZIL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 93.BRAZIL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 94.BRAZIL MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 95.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 96.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 97.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 98.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 99.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 100.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 101.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 102.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 103.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 104.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 105.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 106.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 107.LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 108.LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 109.LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 110.LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 111.ABCAM PLC.: COMPANY SNAPSHOT
TABLE 112.ABCAM PLC.: OPERATING SEGMENTS
TABLE 113.ABCAM PLC.: PRODUCT PORTFOLIO
TABLE 114.ABCAM PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.MESO SCALE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 120.MESO SCALE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 121.MESO SCALE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 122.SEEGENE: COMPANY SNAPSHOT
TABLE 123.SEEGENE: OPERATING SEGMENTS
TABLE 124.SEEGENE: PRODUCT PORTFOLIO
TABLE 125.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 126.BIO-RAD LABORATORIES: OPERATING SEGMENTS
TABLE 127.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 128.BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129.ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 130.ILLUMINA INC.: OPERATING SEGMENTS
TABLE 131.ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 132.ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 133.QIAGEN: COMPANY SNAPSHOT
TABLE 134.QIAGEN NV: OPERATING SEGMENTS
TABLE 135.QIAGEN NV: PRODUCT PORTFOLIO
TABLE 136.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 137.THERMO FISHER: COMPANY SNAPSHOT
TABLE 138.THERMO FISHER: OPERATING SEGMENTS
TABLE 139.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 140.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 141.LUMINEX CORPORATION: COMPANY SNAPSHOT
TABLE 142.LUMINEX CORPORATION: OPERATING SEGMENTS
TABLE 143.LUMINEX CORPORATION: PRODUCT PORTFOLIO
TABLE 144.LUMINEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 145.RANDOX: COMPANY SNAPSHOT
TABLE 146.RANDOX OPERATING SEGMENTS
TABLE 147.RANDOX: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.MULTIPLEX ASSAY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS, 2020
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.LOW THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25.ABCAM PLC.: NET SALES, 2018–2020 ($ MILLION)
FIGURE 26.ABCAM PLC. REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 27.BECTON, DICKINSON AND COMPANY: NET SALES, 2018–2020 ($ MILLION)
FIGURE 28.BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 30.BIO-RAD LABORATORIES: NET SALES, 2018–2020 ($ MILLION)
FIGURE 31.BIO-RAD LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 33.ILLUMINA, INC.: NET SALES, 2018–2020 ($ MILLION)
FIGURE 34.ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 36.QIAGEN NV: NET SALES, 2020–2030 ($ MILLION)
FIGURE 37.QIAGEN: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 38.QIAGEN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 40.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41.THERMO FISHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 42.LUMINEX CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 43.LUMINEX CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
According to the Analyst’s perspective, multiplex assay plays an important role in increasing the efficiency of experiments in clinical laboratories for biomarker validation and diagnosis & treatment of diseases. Recent innovations and constant developments in this field have fueled the adoption of this assays across various applications. For instance, Thermo Fisher Scientific in March 2020, announced the launch of its five new Thermo Scientific SureTect PCR Assay test kits, along with an updated software to test food and related samples. These test kits are used for investigating presence of Cronobacter species, Listeria species, Listeria monocytogenes, Salmonella species, Salmonella Enteritidis, and Salmonella Typhimurium, in food products and consumables. As compared to conventional PCR tests that takes 9 days to give results, the Thermo Scientific SureTect PCR Assay test delivers result in just 24 hours, providing multiplex assay capability up to six STEC targets; hence it is advantageous for commercial testing.
Moreover, multiplex assays are used prominently for protein-based assays, due to increase in R&D activities to introduce novel drug therapies. Additionally, bead-based multiplex assays are used more as they have a larger surface area than planar-based assays, and hence offer a wide range of targets for the detection of proteins and nucleic acids.
A. Multiplex assay are type of immunoassay that uses magnetic beads to simultaneously measure multiple analytes in a single experiment.
A. The total market value of Global Multiplex assay Market is $1,940.49 million in 2020.
A. The forcast period for Global Multiplex assay Market is 2021 to 2030.
A. The market value of Global Multiplex assay Market in 2030 is $4,366.32 million.
A. Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina Inc., Bio Rad Laboratories Inc., and Qiagen N.V. held a high market postion owing to the strong geographical foothold in different regions.
A. Protein based multiplex assay segment dominates the global market, owing to upsurge in adoption of protein-based multiplex assays, and continuously investing in R&D for the introduction of innovative technology.
A. The major factor for the growth of Global Multiplex assay Market are increase in R&D activities & governmental funding, surge in adoption of multiplex assays to reduce operation costs, and rise in adoption of personalized medicines.
A. Owing to rise in the geriatic population in the market. Furthermore, increasing number if covid-19 diseases.
A. The base year is 2020 in Global Multiplex assay Market.
A. Multiplex assays are derived from the ELISA format, but instead of producing a single signal measurement, they produce multiple signal measurements.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
